|
US3172546A
(en)
|
1961-05-19 |
1965-03-09 |
Union Carbide Corp |
Size reduction of biological substances
|
|
US4133814A
(en)
|
1975-10-28 |
1979-01-09 |
Eli Lilly And Company |
2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
|
|
IT1082518B
(it)
|
1977-01-25 |
1985-05-21 |
Fiat Spa |
Specchio a cristallo liquido da impiegare particolarmente come retrovisore per veicoli
|
|
US4418068A
(en)
|
1981-04-03 |
1983-11-29 |
Eli Lilly And Company |
Antiestrogenic and antiandrugenic benzothiophenes
|
|
US4380635A
(en)
|
1981-04-03 |
1983-04-19 |
Eli Lilly And Company |
Synthesis of acylated benzothiophenes
|
|
DK150008C
(da)
|
1981-11-20 |
1987-05-25 |
Benzon As Alfred |
Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
|
|
DE3312671A1
(de)
|
1983-04-08 |
1984-10-11 |
Heinz Finzer KG, 7880 Bad Säckingen |
Stanz- und biegewerkzeug-aggregat
|
|
IT1227626B
(it)
|
1988-11-28 |
1991-04-23 |
Vectorpharma Int |
Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
|
|
JP2642486B2
(ja)
|
1989-08-04 |
1997-08-20 |
田辺製薬株式会社 |
難溶性薬物の超微粒子化法
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
NZ248813A
(en)
|
1992-11-25 |
1995-06-27 |
Eastman Kodak Co |
Polymeric grinding media used in grinding pharmaceutical substances
|
|
US5298262A
(en)
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
|
US5336507A
(en)
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
|
CA2143263C
(en)
|
1994-03-02 |
2002-01-08 |
Kerry John Hartauer |
Orally administrable raloxifene formulations
|
|
US5478705A
(en)
|
1994-05-25 |
1995-12-26 |
Eastman Kodak Company |
Milling a compound useful in imaging elements using polymeric milling media
|
|
US5500331A
(en)
|
1994-05-25 |
1996-03-19 |
Eastman Kodak Company |
Comminution with small particle milling media
|
|
US5631369A
(en)
|
1994-08-31 |
1997-05-20 |
Eli Lilly And Company |
Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
|
|
US5534270A
(en)
|
1995-02-09 |
1996-07-09 |
Nanosystems Llc |
Method of preparing stable drug nanoparticles
|
|
US5591456A
(en)
|
1995-02-10 |
1997-01-07 |
Nanosystems L.L.C. |
Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
IE80467B1
(en)
|
1995-07-03 |
1998-07-29 |
Elan Corp Plc |
Controlled release formulations for poorly soluble drugs
|
|
TW487582B
(en)
|
1995-08-11 |
2002-05-21 |
Nissan Chemical Ind Ltd |
Method for converting sparingly water-soluble medical substance to amorphous state
|
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
|
US6458811B1
(en)
|
1996-03-26 |
2002-10-01 |
Eli Lilly And Company |
Benzothiophenes formulations containing same and methods
|
|
US6713494B1
(en)
|
1996-08-28 |
2004-03-30 |
Eli Lilly And Company |
Amorphous benzothiophenes, methods of preparation and methods of use
|
|
WO1998035666A1
(en)
|
1997-02-13 |
1998-08-20 |
Nanosystems Llc |
Formulations of nanoparticle naproxen tablets
|
|
WO1999009988A1
(en)
|
1997-08-27 |
1999-03-04 |
Hexal Ag |
New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
|
|
US6165506A
(en)
|
1998-09-04 |
2000-12-26 |
Elan Pharma International Ltd. |
Solid dose form of nanoparticulate naproxen
|
|
JP2000095674A
(ja)
|
1998-09-22 |
2000-04-04 |
Sato Pharmaceutical Co Ltd |
口腔内崩壊時間短縮化錠剤の製造方法及び装置
|
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
US20040013613A1
(en)
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
EP1066825A1
(en)
|
1999-06-17 |
2001-01-10 |
The Procter & Gamble Company |
An anti-microbial body care product
|
|
DE19932157A1
(de)
|
1999-07-13 |
2001-01-18 |
Pharmasol Gmbh |
Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
EP1296651B2
(en)
|
2000-06-27 |
2019-07-17 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
|
WO2002017883A2
(en)
|
2000-08-31 |
2002-03-07 |
Rtp Pharma Inc. |
Milled particles
|
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
ATE419834T1
(de)
|
2000-11-20 |
2009-01-15 |
Elan Pharma Int Ltd |
Nanopartikel bestehend aus einem arzneistoff und copolymeren von vinyl pyrrolidon und vinyl acetat als oberflächenstabilisatoren
|
|
DK1337240T4
(en)
|
2000-11-30 |
2015-01-05 |
Vectura Ltd |
A process for the preparation of particles for use in a pharmaceutical composition
|
|
CA2436570A1
(en)
|
2000-12-06 |
2002-06-13 |
Pharmacia Corporation |
Rapidly dispersing pharmaceutical composition comprising effervescent agents
|
|
FI20010115A0
(fi)
|
2001-01-18 |
2001-01-18 |
Orion Corp |
Menetelmä nanopartikkelien valmistamiseksi
|
|
US20020187187A1
(en)
*
|
2001-04-21 |
2002-12-12 |
Toshimitsu Ohki |
Fast disintegrating meloxicam tablet
|
|
US20030087308A1
(en)
|
2001-06-22 |
2003-05-08 |
Elan Pharma International Limited |
Method for high through put screening using a small scale mill or microfluidics
|
|
DE60222160T2
(de)
|
2001-10-12 |
2008-06-12 |
Elan Pharma International Ltd., Athlone |
Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
|
|
US6407128B1
(en)
|
2001-12-03 |
2002-06-18 |
Elan Pharmaceuticals, Inc. |
Method for increasing the bioavailability of metaxalone
|
|
US7714006B1
(en)
|
2001-12-03 |
2010-05-11 |
King Pharmaceuticals Research & Development, Inc. |
Methods of modifying the bioavailability of metaxalone
|
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
US6825161B2
(en)
|
2002-04-26 |
2004-11-30 |
Salvona Llc |
Multi component controlled delivery system for soap bars
|
|
US20060167069A1
(en)
|
2002-09-02 |
2006-07-27 |
Sun Pharmaceutical Industries Ltd. |
Pharmaceutical composition of metaxalone with enhanced oral bioavailability
|
|
JP2004099442A
(ja)
|
2002-09-04 |
2004-04-02 |
Nisshin Pharma Inc |
難溶性薬物含有製剤およびその製造方法
|
|
EP1546138B1
(en)
|
2002-09-30 |
2012-01-18 |
A/S GEA Farmaceutisk Fabrik |
Raloxifene l-lactate or a hemihydrate thereof, their uses, pharmaceutical compositions and preparation processes
|
|
DE10250081A1
(de)
*
|
2002-10-25 |
2004-05-13 |
Boehringer Ingelheim Vetmedica Gmbh |
Wasserlösliche Meloxicam Granulate
|
|
WO2004058216A2
(en)
|
2002-12-17 |
2004-07-15 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
|
US20040121003A1
(en)
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
|
US20050163839A1
(en)
|
2003-01-29 |
2005-07-28 |
Sun Pharmaceutical Industries Limited |
Oral controlled release pharmaceutical composition containing metaxalone as active agent
|
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
|
AU2004238321B2
(en)
|
2003-05-07 |
2009-08-27 |
Samyang Biopharmaceuticals Corporation |
Highly plastic granules for making fast melting tablets
|
|
EP1638527B1
(en)
|
2003-06-27 |
2006-10-25 |
BIOPROGRESS S.p.A. |
Composite product obtainable by cogrinding of an active principle with a copolymer n-vinyl-2-pyrrolidone/vinyl-acetate
|
|
JP2009513512A
(ja)
|
2003-07-09 |
2009-04-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
メロキシカムを含む組成物
|
|
US20050042177A1
(en)
|
2003-07-23 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel compositions of sildenafil free base
|
|
CA2534924A1
(en)
|
2003-08-08 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel metaxalone compositions
|
|
GB0320522D0
(en)
|
2003-09-02 |
2003-10-01 |
Glaxo Group Ltd |
Formulation
|
|
US9149440B2
(en)
|
2003-09-02 |
2015-10-06 |
University Of South Florida |
Nanoparticles for drug-delivery
|
|
MXPA06003599A
(es)
|
2003-10-01 |
2006-06-20 |
Debio Rech Pharma Sa |
Dispositivo y metodo para producir particulas.
|
|
ES2366646T3
(es)
|
2003-11-05 |
2011-10-24 |
Elan Pharma International Limited |
Composiciones en forma de nanopartículas que tienen un péptido como estabilizante superficial.
|
|
MXPA06010146A
(es)
|
2004-03-08 |
2007-05-11 |
Spiridon Spireas |
Formas de dosificacion solidas biodisponibles de metaxalona.
|
|
CA2578709C
(en)
|
2004-06-17 |
2010-06-15 |
Virun, Inc. |
Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents
|
|
WO2006009419A1
(es)
|
2004-07-19 |
2006-01-26 |
Luis Cordova Boone |
Neumáticos con doble banda de rodamiento
|
|
KR20060024927A
(ko)
|
2004-09-15 |
2006-03-20 |
씨제이 주식회사 |
기계적 분쇄법에 의한 미크론 사이즈 인삼 분말의제조방법
|
|
WO2006041843A2
(en)
|
2004-10-04 |
2006-04-20 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical dosage form comprising meloxicam
|
|
US9504658B2
(en)
|
2004-11-09 |
2016-11-29 |
Board Of Regents, The University Of Texas System |
Stabilized HME composition with small drug particles
|
|
UA89513C2
(uk)
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
|
CN104083342A
(zh)
|
2004-12-31 |
2014-10-08 |
伊休蒂卡有限公司 |
纳米微粒组合物及其合成方法
|
|
DE602006013114D1
(de)
|
2005-04-28 |
2010-05-06 |
Wyeth Corp |
Mikronisiertes tanaproget und zusammensetzungen damit
|
|
JO3352B1
(ar)
|
2005-06-17 |
2019-03-13 |
Apr Applied Pharma Res Sa |
صيغ دايكلوفيناك وطرق استخدامه
|
|
SG166115A1
(en)
*
|
2005-09-30 |
2010-11-29 |
Boehringer Ingelheim Vetmed |
Pharmaceutical preparation containing meloxicam
|
|
US20080292584A1
(en)
|
2005-10-14 |
2008-11-27 |
Mutual Pharmaceutical Company, Inc. |
Metaxalone products, method of manufacture, and method of use
|
|
CA2631493A1
(en)
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
JP2009519970A
(ja)
|
2005-12-15 |
2009-05-21 |
アキュスフィア， インコーポレイテッド |
粒子ベースの経口投与用製薬剤形の製造方法
|
|
WO2007070852A2
(en)
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for parenteral administration
|
|
WO2007074477A2
(en)
|
2005-12-29 |
2007-07-05 |
Dabur Pharma Limited |
Metaxalone polymorphs
|
|
US8420122B2
(en)
|
2006-04-28 |
2013-04-16 |
Merck Sharp & Dohme Corp. |
Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
|
|
JP2009541360A
(ja)
|
2006-06-23 |
2009-11-26 |
エラン・ファルマ・インターナショナル・リミテッド |
ナノ粒子状メロキシカムおよび制御放出ヒドロコドンを含む組成物
|
|
CN102895194B
(zh)
|
2006-06-30 |
2015-09-09 |
伊休蒂卡有限公司 |
用于制备纳米粒形式的生物活性化合物的方法
|
|
EP2054042B8
(en)
|
2006-06-30 |
2020-06-10 |
iCeutica Pty Ltd |
Methods for the preparation of biologically active compounds in nanoparticulate form
|
|
CN100386312C
(zh)
|
2006-07-18 |
2008-05-07 |
上海世景国际贸易有限公司 |
2，4-二氨基苯磺酸及其盐的合成方法
|
|
KR20090027734A
(ko)
|
2006-07-27 |
2009-03-17 |
(주)아모레퍼시픽 |
난용성 약물의 나노입자를 포함하는 분말의 제조방법
|
|
PE20081891A1
(es)
|
2007-03-22 |
2008-12-27 |
Opko Health Inc |
Formulaciones de comprimidos que contienen sales de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-spiro[4.5]decan-2-ona y comprimidos elaborados a partir de estas
|
|
TWI405590B
(zh)
|
2007-04-06 |
2013-08-21 |
Activus Pharma Co Ltd |
微粉碎化有機化合物粒子之製法
|
|
AR067997A1
(es)
|
2007-08-24 |
2009-10-28 |
Novartis Ag |
Compuestos organicos
|
|
RU2010153904A
(ru)
|
2008-06-02 |
2012-07-20 |
Др. Редди'С Лабораторис Лтд. (In) |
Ниацин-содержащие композиции с модифицированным высвобождением
|
|
US8568696B2
(en)
|
2008-08-06 |
2013-10-29 |
Indiana Nanotech Llc |
Grinding method for the manipulation or preservation of calcium phosphate hybrid properties
|
|
WO2010121324A1
(en)
|
2009-04-24 |
2010-10-28 |
Iceutica Pty Ltd |
A novel formulation of metaxalone
|
|
CN102438592B
(zh)
|
2009-04-24 |
2016-09-14 |
伊休蒂卡有限公司 |
甲氧萘普酸的剂型
|
|
CN102438593A
(zh)
|
2009-04-24 |
2012-05-02 |
伊休蒂卡有限公司 |
高体积分数的包封纳米颗粒的制备
|
|
EP2421525B1
(en)
|
2009-04-24 |
2017-06-07 |
Iceutica Pty Ltd. |
Diclofenac formulation
|
|
US20120160944A1
(en)
|
2009-04-24 |
2012-06-28 |
Aaron Dodd |
Method for the production of commercial nanoparticle and micro particle powders
|
|
KR20120059452A
(ko)
*
|
2009-04-24 |
2012-06-08 |
아이슈티카 피티와이 리미티드 |
신규 멜록시캄 제제
|
|
NZ595984A
(en)
|
2009-04-24 |
2014-04-30 |
Iceutica Pty Ltd |
Production of encapsulated nanoparticles at commercial scale
|
|
MY159208A
(en)
|
2009-04-24 |
2016-12-30 |
Iceutica Pty Ltd |
A novel formulation of indomethacin
|
|
CA2759104C
(en)
|
2009-04-24 |
2019-01-29 |
Iceutica Pty Ltd |
Method for improving the dissolution profile of a biologically active material
|
|
US8545879B2
(en)
*
|
2009-08-31 |
2013-10-01 |
Wilmington Pharmaceuticals, Llc |
Fast disintegrating compositions of meloxicam
|
|
US20160159756A1
(en)
|
2013-07-22 |
2016-06-09 |
Iceutica Inc. |
Formulation of metaxalone
|
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|